Evidence map›Paper›PMID 34461736›Full record

ArticleCirculation. Genomic and precision medicine2021

Thrombotic Risk Determined by

Eric Manderstedt, Christer Halldén, Christina Lind-Halldén, Johan Elf, Peter J Svensson, Gunnar Engström, Olle Melander, Aris Baras, Luca A Lotta, Bengt Zöller and 1 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Circulation. Genomic and precision medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Rare variants inERJ open research · 2025
    Article
  5. Thrombotic risk determined byResearch and practice in thrombosis and haemostasis · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Eric ManderstedtDepartment of Environmental Science and Bioscience, Kristianstad University, Kristianstad (E.M., C.H., C.L.-H.).
Christer HalldénDepartment of Environmental Science and Bioscience, Kristianstad University, Kristianstad (E.M., C.H., C.L.-H.).ORCID 0000-0002-9355-3901
Christina Lind-HalldénDepartment of Environmental Science and Bioscience, Kristianstad University, Kristianstad (E.M., C.H., C.L.-H.).
Johan ElfDepartment of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden (J.E., P.J.S., G.E., O.M.).
Peter J SvenssonDepartment of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden (J.E., P.J.S., G.E., O.M.).ORCID 0000-0003-2901-6877
Gunnar EngströmDepartment of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden (J.E., P.J.S., G.E., O.M.).ORCID 0000-0002-8618-9152
Olle MelanderDepartment of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden (J.E., P.J.S., G.E., O.M.).
Aris BarasRegeneron Genetics Center, Tarrytown, NY (A.B., L.A.L.).
Luca A LottaRegeneron Genetics Center, Tarrytown, NY (A.B., L.A.L.).
Bengt ZöllerCenter for Primary Health Care Research, Lund University & Region Skåne, Malmö, Sweden (B.Z.).ORCID 0000-0002-8250-5613
Regeneron Genetics Center*

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cohort StudiesHumansRisk Factorsgeneticspopulationriskthrombosisvenous thromboembolism

Identifiers

PMID34461736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.